Skip to content

Validation of the diffusion MRI signal in kidney tumours: a pilot study

Validation of the diffusion MRI signal in kidney tumours: a pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON24559
Enrollment
21
Registered
2015-03-18
Start date
2015-05-27
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney, kindey tumor, renal cell carcinoma

Interventions

Diffusion MRI scan, including diffusion-tensor imaging (DTI), intra-voxel incoherent motion (IVIM) and tractography

Sponsors

University of Twente
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: * Volunteers are healthy * Volunteers and subjects are 18 year or older. • Volunteers and subjects are capable and prepared to sign an informed consent. • Subjects are eligible for radical nephrectomy • Subjects are planned to undergo nephrectomy

Exclusion criteria

Exclusion criteria: • Subjects and volunteers with contra-indications for MRI (like a pacemaker, claustrophobia). • Subjects and volunteers with large (known) deviation in kidney anatomy (like horseshoe kidney). • Refusal of volunteers and subjects to be informed of chance findings possibly relevant to their health. • Subjects and volunteers with kidney pathologies (other than kidney tumor)

Design outcomes

Primary

MeasureTime frame
De primaire onderzoeksvariabelen zijn de diffusie-MRI verkregen parameters: FA, MD, pseudodiffusie coefficienten en perfusie fracties. Deze worden gecorreleerd aan de histologisch vastgestelde tumor type (clear cell, chromophobe, cystic en papillary renal cell carcinoma).

Contacts

Public ContactS. van Baalen

Postbus 217

s.j.vanbaalen@utwente.nl+31 53 489 5596

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)